Bone morphogenetic protein-2 and transforming growth factor-β2 interact to modulate human bone marrow stromal cell proliferation and differentiation

Journal of Cellular Biochemistry

Volumn 68, Issue 4, 1998, Pages 411-426

  Fromigue O ^a   Marie, P J ^a   Lomri, A ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

BMP 2; Bone marrow stroma; Differentiation; Human; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL;

ALKALINE PHOSPHATASE; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COLLAGEN; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION; HUMANS; OSTEOBLASTS; OSTEOCALCIN; RECOMBINANT PROTEINS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032521349     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T     Document Type: Article

References (39)

1. Amédée J, Bareille R, Rouais F, Cunningham N, Reddi H, Harmand MF (1994): Osteogenin (bone morphogenetic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. Differentiation 58:157-164.
2. Beresford JN, Joyner CJ, Devlin C, Triffitt JT (1994): The effects of dexamethasone and 1,25-dihydroxyvitamin D on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39:941-947.
3. Bonewald LF, Dallas SL (1994): Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350-357.
4. Breen EC, Ignotz RA, McCabe L, Stein JL, Stein G, Lian JB (1994): TGFβ alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160:323-335.
5. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM (1990): Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847.
6. Centrella M, McCarthy TL, Canalis E (1987): Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874.
7. Centrella M, Horowitz MC, Wozney JM, McCarthy TL (1994): Transforming growth factor β gene family members and bone. Endocr Rev 15:27-35.
8. Chen TL, Bates RL, Dudley A, Hammonds RG Jr, Amento EP (1991): Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: Comparison with TGF-β1. J Bone Miner Res 6:1387-1393.
9. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994): Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
10. Dieudonné SC, Semeins CM, Goei SW, Vukicevic S, Nulend JK, Sampath TK, Helder M, Burger EH (1994): Opposite effects of osteogenin protein and transforming growth factor β on chondrogenesis in cultured long bone rudiments. J Bone Miner Res 9:771-780.
11. Friedenstein AJ (1976): Precursor of mechanocytes. Int Rev Cytol 47:327-355.
12. Fromigué O, Hott M, Marie PJ, Lomri A (1996): Establishment and characterization of a new osteoblastic cell line derived from fetal human bone marrow stroma after functional insertion of the SV-40 large T oncogen. J Bone Miner Res 11:S388 (abst).
13. Fromigué O, Marie PJ, Lomri A (1997): Differential effects of transforming growth factor-β, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9:613-623.
14. Gehron-Robey P, Young MF, Flanders KC, Roche NS, Kondaiah P, Redi AH, Termine JD, Sporn MB, Roberts AB (1987): Osteoblasts synthesize and respond to transforming growth factor type β (TGF-β) in vitro. J Cell Biol 105:457-463.
15. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney JM, Mundy GR (1994): Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863.
16. Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A, Suzuki F (1991): Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 6:1373-1385.
17. Hugues FJ, Collyer J, Stanfield M, Goodman SA (1995): The effects of bone morphogenetic protein-2, -4 and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136:2671-2677.
18. Ignotz RA, Massague J (1986): Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345.
19. Ingram RT, Bonde SK, Riggs BL, Fitzpatrick LA (1994): Effects of transforming growth factor beta (TGF-β) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 55:153-163.
20. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T (1990): The non-osteogenic mouse pluripotent cell line C3H10T1/2 is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-299.
21. Kingsley DM (1994): The -β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes and development 8:133-146.
22. Linkhart TA, Mohan S, Baylink DJ (1996): Growth factors for bone growth and repair: IGF, TGF-β and BMP. Bone 19:1S-12S.
23. Lomri A, Marie PJ (1990): Effects of transforming growth factor type Ζ on expression of cytoskeletal proteins in endosteal mouse osteoblastic cells. Bone 11:445-451.
24. Long MW, Robinson JA, Ashcraft EA, Mann KG (1995): Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95: 881-887.
25. Machwate M, Zerath E, Holy X, Hott M, Godet D, Lomri A, Marie PJ (1995): Systemic administration of transforming growth factor-β2 prevents the impaired bone formation and osteopenia induced by unloading in rats. J Clin Invest 96:1245-1253.
26. Marie PJ (1997): Effects of bone morphogenetic proteins on cells of the osteoblastic lineage. J Cell Eng 2(3):92-99.
27. Noda M, Camillière JJ (1989): In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:2991-2994.
28. Owen ME (1988): Marrow stromal stem cells. J Cell Sci (suppl 0):63-76.
29. Oyajobi BO, Lomri A, Hott M, Marie PJ (1997): A novel immortalized STRO-1+ , ALP-osteoprogenitor cell line established from an immunoselected population of fetal human bone marrow cells. J Bone Miner Res 12:S201 (abst).
30. Pfeilschifter J, Oechsner M, Nauman A, Gronwald RGK, Minne HW, Ziegler R (1990): Stimulation of bone matrix apposition in vitro by local growth factors: A comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor β. Endocrinology 127:69-75.
31. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I (1994): Induction of rapid osteoblast differentiation in rat bone marrow stromal cell culture by dexamethasone and BMP-2. Dev Biol 161:218-228.
32. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RHL, Corbett C, Ozkaynak E, Oppermann H, Rueger DC (1992): Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 26:20352-20362.
33. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V (1992): Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324.
34. Urist MR (1965) Bone formation by autoinduction. Science 150:893-899.
35. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel D, Hewick RM, Kerns K.M, Lapan P, Luxenberg DP, Mcquaid D, Moutsatsos IK, Nove J, Wozney JM (1990): Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224.
36. West DC, Sattar A, Kumar S (1985): A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal Biochem 147:289-295.
37. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988): Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
38. Wozney JM (1992): The bone morphogenetic protein family and osteogenesis. Mol Rep Dev 32:160-167.
39. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S (1996): Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/ PA6. Biochem Biophys Res Commun 220:366-371.